Back to results
US 2020/0208173 A1Published application
Adenovirus control virus
AssigneeSeracare Life Sciences, Inc.
InventorsBharathi Anekella, Catherine Huang
Life of this patent
Estimating the term…
Abstract
Disclosed are compositions and methods related to replication deficient adenoviruses that are able to function as controls for nucleic acid diagnostic assays (e.g., nucleic acid sequencing based assays and/or nucleic acid amplification based assays).
Claims25
A replication deficient recombinant adenovirus lacking E1 activity, comprising a genome comprising adenovirus genomic DNA sequence and a heterologous DNA sequence.
13-15. (canceled)
(canceled)
(canceled)
20-26. (canceled)
32-34. (canceled)
Dependencies are inferred from the claim text.